Khiron Life Sciences Corp.
Rank 107
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.0854
USD
4.55%
Market cap
$9,729,406
Total volume
$19,514
Shares outstanding
113,927,120
Rank 107
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
Exchange | Symbol | Volume (24h) | Volume (%) | Price |
---|---|---|---|---|
|
KHRN |
$4,987
|
25.56% |
$0.0854
|
KHRNF |
Total volume
$14,527
|
74.44% |
Stock price
$0.4213
|
Chart